| 000 | 01883 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515140203.0 | ||
| 264 | 0 | _c20091023 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1878-5875 | ||
| 024 | 7 |
_a10.1016/j.biocel.2008.08.037 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmith, Aaron G | |
| 245 | 0 | 0 |
_aPPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells. _h[electronic resource] |
| 260 |
_bThe international journal of biochemistry & cell biology _cApr 2009 |
||
| 300 |
_a844-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCOS Cells |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChlorocebus aethiops |
| 650 | 0 | 4 |
_aChromans _xpharmacology |
| 650 | 0 | 4 |
_aHalofenate _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aPPAR gamma _xagonists |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
| 650 | 0 | 4 | _aTroglitazone |
| 650 | 0 | 4 |
_aWnt Proteins _xagonists |
| 650 | 0 | 4 |
_abeta Catenin _xgenetics |
| 700 | 1 | _aBeaumont, Kimberley A | |
| 700 | 1 | _aSmit, Darren J | |
| 700 | 1 | _aThurber, Amy E | |
| 700 | 1 | _aCook, Anthony L | |
| 700 | 1 | _aBoyle, Glen M | |
| 700 | 1 | _aParsons, Peter G | |
| 700 | 1 | _aSturm, Richard A | |
| 700 | 1 | _aMuscat, George E O | |
| 773 | 0 |
_tThe international journal of biochemistry & cell biology _gvol. 41 _gno. 4 _gp. 844-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biocel.2008.08.037 _zAvailable from publisher's website |
| 999 |
_c18289172 _d18289172 |
||